- Home
- TVRD vs FRST Comparison
TVRD vs FRST Comparison
Compare TVRD & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- FRST
- Stock Information
- Founded
- TVRD 2017
- FRST 2004
- Country
- TVRD United States
- FRST United States
- Employees
- TVRD N/A
- FRST N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- FRST Major Banks
- Sector
- TVRD Health Care
- FRST Finance
- Exchange
- TVRD Nasdaq
- FRST Nasdaq
- Market Cap
- TVRD 246.5M
- FRST 265.8M
- IPO Year
- TVRD N/A
- FRST 2006
- Fundamental
- Price
- TVRD $29.44
- FRST $11.35
- Analyst Decision
- TVRD Strong Buy
- FRST Buy
- Analyst Count
- TVRD 5
- FRST 1
- Target Price
- TVRD $59.20
- FRST $420.00
- AVG Volume (30 Days)
- TVRD 93.5K
- FRST 84.6K
- Earning Date
- TVRD 08-21-2025
- FRST 07-24-2025
- Dividend Yield
- TVRD N/A
- FRST 3.52%
- EPS Growth
- TVRD N/A
- FRST N/A
- EPS
- TVRD N/A
- FRST 0.16
- Revenue
- TVRD N/A
- FRST $125,133,000.00
- Revenue This Year
- TVRD N/A
- FRST $21.33
- Revenue Next Year
- TVRD N/A
- FRST $12.77
- P/E Ratio
- TVRD N/A
- FRST $70.69
- Revenue Growth
- TVRD N/A
- FRST 22.34
- 52 Week Low
- TVRD $8.13
- FRST $7.59
- 52 Week High
- TVRD $34.31
- FRST $13.52
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- FRST 71.92
- Support Level
- TVRD N/A
- FRST $10.40
- Resistance Level
- TVRD N/A
- FRST $11.41
- Average True Range (ATR)
- TVRD 0.00
- FRST 0.25
- MACD
- TVRD 0.00
- FRST 0.04
- Stochastic Oscillator
- TVRD 0.00
- FRST 92.00
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.